Pricing

Unity Biotechnology Inc (UBX)

followers ·
Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Anirvan Ghosh
Employees:
60
285 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA, 94080
(650) 416-1192
Stock Split History
DateRatio
2022-10-20 1:10
Unity Biotechnology, Inc. engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available